Health Care/Hospital
Philippine Red Cross launches RC143 contact tracing app with data-free usage for Smart mobile subscribers
MANILA, Philippines, May 14, 2020 /PRNewswire/ -- The Philippine Red Cross (PRC) has launched a new mobile application called RC143 which is designed to help health authorities in contact tracing of COVID-19 cases. Smart is enabling its subscribers to download and use the mobile app free of data ...
2020-05-14 08:00
14638
Venture Capitalists and Industry Leaders Unite to Support Startup Community in First-Of-Kind Mentoring and Charity Fundraising Campaign
SINGAPORE, May 14, 2020 /PRNewswire/ -- More than 140 Venture firms, accelerators, incubators and other members of the startup community inSoutheast Asia are coming out strongly to support a community-led charity fundraising campaign aiming to raise the equivalent of 50,000 meals for those in nee...
2020-05-14 08:00
4730
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, May 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today jointl...
2020-05-14 07:30
9060
Hanwha Helps the Fight Against COVID-19 by Providing Life Park, a Smart Training Institute in the City of Yongin, Gyeonggi Province in Korea, as a Treatment Center
SEOUL, South Korea, May 14, 2020 /PRNewswire/ -- Hanwha is closely monitoring
the COVID-19 global health crisis and implementing various measures to protect
the health and safety of their employees and slow the spread of coronavirus by
helping hard-hit communities.
2020-05-14 07:00
2541
VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting
AUSTIN, Texas, May 13, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), an epigenetics company developing simple, easy to use and cost effective blood tests to help diagnose a range of cancers, will present three abstracts at the 2020 ASCO Annual Meeting. The first abs...
2020-05-14 06:54
8037
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
- Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, biomarker and HRQoL analyses for tepotinib†, the first MET inhibitor to have received a regulatory approval for NSCLC withMET gene alterations - Two-year follow-up for first-in-class bifunctional im...
2020-05-14 06:46
2526
Frost & Sullivan Assesses the Top 21 Global Risks that Threaten the Next Decade
Inability to mitigate global risks such as rise of infectious diseases like COVID-19 can adversely impact businesses, societies, and economies SANTA CLARA, California, May 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Global Future Risks—Future-proofing Your Strategies, 2030, provi...
2020-05-14 03:44
1917
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
HYDERABAD, India, May 14, 2020 /PRNewswire/ -- Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distributio...
2020-05-14 01:56
3490
Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan
Demand for telehealth will soar by 64.3% in the US in 2020 as the COVID-19 pandemic disrupts the practice of medicine and the delivery of healthcare SANTA CLARA, California, May 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Telehealth—A Technology-Based Weapon in the War Against the...
2020-05-14 01:05
2950
Trip.com Group joins WTTC in launching Safe Travels protocol
SHANGHAI, May 14, 2020 /PRNewswire/ -- Leading international online travel services provider (OTA) Trip.com Group today announced its role in overseeing the implementation of an industry initiative led by the World Travel and Tourism Council (WTTC), set to lend impetus to the revival of the secto...
2020-05-14 01:03
3017
Dreamwood(TM) Offers Olfactive Warmth, Cosmetic Benefits and Positive Impact
GENEVA, May 13, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned perfume and taste company, is proud to launch its newest exclusive, captive ingredient Dreamwood™. Inspired by the iconic Mysore sandalwood, Dreamwood™ offers the signature mystical, creamy olfactive warmth with ...
2020-05-13 21:53
2469
DERMALOG Fever Detection Protects Draegerwerk AG Production
- Despite Covid-19, assembly lines in many factories do not stop. Production at Draeger is also in full operation. As a manufacturer of ventilators, the German company's products are currently in high demand. To keep the risk of infection among employees as low as possible, Draeaeger has implemen...
2020-05-13 21:10
1602
Havas Health & You Launches Havas Mango
NEW YORK, May 13, 2020 /PRNewswire/ -- In 2019, wellness was one of the fastest growing consumer priorities in the world. In 2020, as we face a new health reality globally, this priority has become critical, as consumers are thinking more about personal and collective wellbeing than perhaps ever ...
2020-05-13 21:10
1166
AIA Brings Its Global Ambassador, David Beckham, and Partner, Tottenham Hotspur, Together to Promote Healthier, Longer, Better Lives
SINGAPORE, May 13, 2020 /PRNewswire/ -- AIA, the largest independent publicly listed pan-Asian life insurance group, today launched a new content series (filming was conducted prior to theCOVID-19 pandemic) in partnership with its Global AmbassadorDavid Beckham and partner Tottenham Hotspur Footb...
2020-05-13 20:43
1742
Happiness Biotech Announced Innovative Cultivation Technology of Lucidum
NANPING, China, May 13, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has successfully developed an innovative cultivation technology of lucidum, which...
2020-05-13 20:00
4627
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors
SHANGHAI and ROCKVILLE, Md., May 13, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, today announ...
2020-05-13 20:00
5351
Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19
IRVINE, California, May 13, 2020 /PRNewswire/ -- Irvine, California-based
Fluxergy LLC, a diagnostic test company, is making a$30 million investment to
expand its capability to scale production of the Fluxergy Analyzer diagnostic
testing system in response to the COVID-19 pandemic.
2020-05-13 18:41
3252
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
HANGZHOU, China and SHAOXING, China, May 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from China's National Medical Products Administration (NMPA) for its in-house developed Category 1 Drug ASC41 to conduct clinical trials for Non-al...
2020-05-13 18:30
3057
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months
* CMAB completed a full scope development and manufacturing project for Q-1802 in 9 months for dual IND filing inChina and the US * Completion of the project demonstrates the significant speed to clinic achievable with CMAB's fully integrated development and manufacturing platform * QureBio'...
2020-05-13 18:29
2638
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment
MUMBAI, India, May 13, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (and hereafter referred to as "Cipla") today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine R...
2020-05-13 17:51
3448
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
